H.C. Wainwright Reiterates Buy Rating, $73 Price Target on Celldex Therapeutics (CLDX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 29.45 -0.26 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.71 | 52 Week High | $18.62 | |||
| Open | $30.53 | 52 Week Low | $2.85 | |||
| Day High | $30.92 | P/E | N/A | |||
| Day Low | $28.78 | EPS | $-1.02 | |||
| Volume | 79,543 | |||||
